Yale researchers have, for the first time, identified two types of reading disability: a primarily inherent type with higher cognitive ability (poor readers who compensate for disability), and a more environmentally influenced type with lower cognitive...
On July 7, 70 students from New Haven’s Hill Regional Career High School will begin to study science and medicine on the Yale University campus as part of Yale’s outreach program for public school students in the city. The Yale University Science...
President Richard C. Levin today named Dr. Dennis D. Spencer, the Harvey and Kate Cushing Professor of Neurosurgery and Chair of Neurosurgery, as acting dean of the Yale School of Medicine. Spencer, who has an international reputation in the surgical...
Women are affected more than men by certain stressful life events, a factor that can contribute to their inability to quit smoking or their decision to resume smoking, according to a new study from Yale researchers. Health problems and financial...
Adolescents are more vulnerable than any other age group to developing nicotine, alcohol and other drug addictions because the regions of the brain that govern impulse and motivation are not yet fully formed, Yale researchers have found. After...
New York Magazine has included 55 Yale School of Medicine physicians on a list of the top doctors in the metropolitan area for 2003. Spanning a wide variety of specialties from cardiology to dermatology and geriatrics and surgery, the list serves as a...
Robert Shulman, a Yale professor and key figure in the implementation of nuclear magnetic resonance imaging (NMR) technology for biological studies, will be honored at a symposium at Yale School of Medicine June 17. The most popular mode of NMR...
Dr. Jeffrey P. Koplan will join the Yale Corporation as an Alumni Fellow for a six-year term beginning July 1, University President Richard C. Levin has announced. Koplan is vice president for Academic Health Affairs at Emory University and former...
Bayer Pharmaceuticals Corporation has created a $2 million endowment to help advance cutting-edge medical research at Yale School of Medicine. Through this new program, called the Bayer Endowment for Scholars in Medicine and Management, a fellowship...
Bayer Pharmaceuticals Corporation has created a $2 million endowment to help advance cutting-edge medical research at Yale School of Medicine. Through this new program, called the Bayer Endowment for Scholars in Medicine and Management, a fellowship...